Comparison of the Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Healthy Japanese and Caucasian Subjects

被引：0
|
作者：
Hiroyuki Oshima
Takao Yamazaki
Lauren Benner
Takashi Miki
Ingrid Michon
Tomasz Wojtkowski
Atsunori Kaibara
Salim Mujais
机构：
[1] Astellas Pharma Inc.,
[2] Astellas Pharma Global Development,undefined
[3] Inc.,undefined
[4] Astellas Pharma Global Development,undefined
[5] Inc.,undefined
来源：
Clinical Drug Investigation | 2015年 / 35卷
关键词：
Multiple Dose; Japanese Subject; Caucasian Subject; Fidaxomicin; Japanese Group;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：375 / 384
页数：9
相关论文
共 50 条
  • [21] Pharmacokinetics of repaglinide in healthy Caucasian and Japanese subjects
    Thomsen, MS
    Chassard, D
    Evène, E
    Nielsen, KK
    Jorgensen, M
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (01): : 23 - 28
  • [22] A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects
    Harada-Shiba, Mariko
    Ali, Shazia
    Gipe, Daniel A.
    Gasparino, Evelyn
    Son, Vladimir
    Zhang, Yi
    Pordy, Robert
    Catapano, Alberico L.
    ATHEROSCLEROSIS, 2020, 314 : 33 - 40
  • [23] Multiple-Dose Pharmacokinetics, Safety, and Tolerability of Aprocitentan, a Dual Endothelin Receptor Antagonist, in Healthy Japanese and Caucasian Subjects
    Fontes, Magda S. C.
    Dingemanse, Jasper
    Sidharta, Patricia N.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (07): : 718 - 725
  • [24] Pharmacokinetics, safety, and tolerability of rotigotine transdermal system in healthy Japanese and Caucasian subjects following multiple-dose administration
    Cawello, Willi
    Kim, Seong Ryul
    Braun, Marina
    Elshoff, Jan-Peer
    Masahiro, Takeuchi
    Ikeda, Junji
    Funaki, Tomoo
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2016, 41 (04) : 353 - 362
  • [25] Clinical pharmacokinetics, pharmacodynamics, safety and tolerability of darexaban, an oral direct factor Xa inhibitor, in healthy Caucasian and Japanese subjects
    Kadokura, Takeshi
    Kashiwa, Makoto
    Groenendaal, Dorien
    Heeringa, Marten
    Mol, Roelof
    Verheggen, Frank
    Garcia-Hernandez, Alberto
    Onkels, Hartmut
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2013, 34 (08) : 431 - 441
  • [26] Pharmacokinetics, safety, and tolerability of rotigotine transdermal system in healthy Japanese and Caucasian subjects following multiple-dose administration
    Willi Cawello
    Seong Ryul Kim
    Marina Braun
    Jan-Peer Elshoff
    Takeuchi Masahiro
    Junji Ikeda
    Tomoo Funaki
    European Journal of Drug Metabolism and Pharmacokinetics, 2016, 41 : 353 - 362
  • [27] Pharmacokinetics and safety of single and multiple doses of rasagiline in healthy Japanese and caucasian subjects
    Elgart, Anna
    Rabinovich-Guilatt, Laura
    Eyal, Eli
    Gross, Aviva
    Spiegelstein, Ofer
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 124 (03) : 273 - 284
  • [28] Pharmacokinetics, safety, and tolerability of ceftolozane/tazobactam in healthy Japanese, Chinese, and white subjects
    Aiudi, Anthony
    Miller, Benjamin
    Krishna, Gopal
    Adedoyin, Adedayo
    Xiao, Alan
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 (06) : 625 - 633
  • [29] Opicapone pharmacokinetics and pharmacodynamics comparison between healthy Japanese and matched Caucasian subjects
    Rocha, J. F.
    Falcao, A.
    Lopes, N.
    Santos, A.
    Nunes, T.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 362 - 362
  • [30] Pharmacokinetics, Pharmacodynamics, Pharmacogenomics, Safety, and Tolerability of Avatrombopag in Healthy Japanese and White Subjects
    Nomoto, Maiko
    Pastino, Gina
    Rege, Bhaskar
    Aluri, Jagadeesh
    Ferry, Jim
    Han, David
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (02): : 188 - 195
12345